Role of the FDA in Affordability of Off-Patent Pharmaceuticals
jama.jamanetwork.com/article.aspx?articleID=2480263
6 hours ago - Although markets for some drugs remain vigorous long after patent ...First, FDA should consider temporarily permitting compounding of the drug at
JAMA
No comments:
Post a Comment